The College of Physicians and Surgeons of British Columbia is currently pursuing a permanent restraining order against the initiator of a well-known online service that offers “personalized cancer care and precision oncology,” aiming to prevent the individual from evaluating patients and providing medical guidance. The legal action, lodged in the British Columbia Supreme Court, alleges that Alexander Rolland is breaching provincial health regulations by running Cancer Treatment Options and Management Inc.
The filed petition asserts that Rolland’s websites and his self-proclaimed identity as “The Cancer Guy” on a YouTube channel collectively suggest that he and his associates are capable of conducting activities restricted to regulated health practitioners. Allegedly, Rolland and his team are engaging in activities falling within the realm of medical practice, such as diagnosing, assessing patient health, recommending treatments, managing treatments, preventing diseases, offering physical health advice, and crafting therapeutic diets.
Despite the petition, Rolland has not formally responded. Co-founder Michelle Morand of Cancer Treatment Options and Management mentioned in a conversation with CBC News that they have not received the court documents and emphasized that the company operates lawfully. Morand clarified that their role is not to treat or prescribe but to facilitate access to services beyond what the conventional healthcare system provides, supporting patients in advocating for advanced technologies and treatments from their healthcare providers.
According to online information, Rolland attained a bachelor’s degree in science from the University of Victoria and completed his PhD studies in medical genetics at the Terry Fox Laboratory in Vancouver, affiliated with the B.C. Cancer Research Institute. Statements from a B.C. Cancer Research Institute spokesperson revealed that Rolland was engaged in research at the laboratory during his enrollment as a graduate student at the University of British Columbia.
Described as a private entity collaborating within mainstream healthcare to enhance cancer patients’ care quality, Cancer Treatment Options and Management addresses the limitations within the healthcare system that hinder the dissemination of cutting-edge diagnostic measures and treatments to frontline healthcare teams. The company’s mission, as highlighted in their promotional material, is to bridge the gap between innovative cancer research and patient care, ultimately aiming to render their services obsolete by improving cancer care standards.
Nevertheless, the College of Physicians and Surgeons of British Columbia alleges that Rolland has exceeded the boundaries of medical regulations in the province by actively participating in monitoring treatment plans and recommending treatments to clients referred to as “patients” in reports shared with physicians. The court documents indicate that the services provided by Rolland and his associates range from $2,000 to $20,000, with additional costs potentially reaching up to $10,000 per month for recommended medications, necessitating clients to pay upfront and even suggesting setting up fundraising campaigns for financial support.
The petition also raises concerns about consultants named in the legal action who hold medical licenses in other jurisdictions but are prohibited from dispensing medical advice in British Columbia without proper provincial licensing. Affidavits supporting the petition were submitted by two B.C. Cancer medical oncologists, detailing instances where patients sought second opinions from Rolland’s company, resulting in strained relationships between patients and their primary care providers.
One oncologist recounted a scenario where a patient with brain cancer received recommendations for experimental drugs not covered by B.C. Cancer, leading to discordance in the treatment approach. Another oncologist described an incident involving a patient with ovarian cancer who received conflicting advice from Rolland’s company, causing distress and mistrust in the patient-oncologist relationship. These testimonies underscore the potential repercussions of seeking medical guidance outside the established healthcare system.
Despite the ongoing legal dispute, Cancer Treatment Options and Management maintains its transparency with clients regarding the nature of their services and clients’ informed consent. Morand emphasized that patients are aware of the company’s role as non-oncologists providing informational support and alternative treatment options, acknowledging the clients’ desire for comprehensive care beyond conventional healthcare offerings.
It is important to note that the allegations presented in the petition have not been proven in court, highlighting the complexity of navigating non-traditional healthcare avenues and the potential impacts on patients, healthcare providers, and regulatory authorities.